XENE - CIK 0001582313
Xenon Pharmaceuticals Inc. (XENE) reported revenue of $311.00K for fiscal year 2017, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2017 | $311.00K | -82.8% |
| FY 2016 | $1.80M | -88.4% |
| FY 2015 | $15.58M | -45.1% |
| FY 2014 | $28.37M | +3.7% |
| FY 2013 | $27.36M | +91.2% |
| FY 2012 | $14.31M | - |
Xenon Pharmaceuticals Inc. (XENE) reported revenue of $311.00K for fiscal year 2017, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2017, Xenon Pharmaceuticals Inc.'s revenue declined from $14.31M to $311.00K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.